Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 8035.T
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.68 2.78 2.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -15.23 -2.79 -2.42
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 10.27 3758.42 3408.26
Cash 32.53 1009.01 761.32
Capex -100.00 -47.57 0.00
Free Cash Flow 317.47 249.34 59.73
Revenue 16.66 1168.61 1001.69
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -2.31 0.47 0.48
Operating Margin -7.12 0.27 0.29
ROA 11.08 0.05 0.05
ROE 10.29 0.07 0.06
ROIC -17.64 0.07 0.08
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 8035.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 8035.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 8035.T is permitted for members.